171 related articles for article (PubMed ID: 16601258)
1. NMDA receptor antagonism disrupts the development of morphine analgesic tolerance in male, but not female C57BL/6J mice.
Bryant CD; Eitan S; Sinchak K; Fanselow MS; Evans CJ
Am J Physiol Regul Integr Comp Physiol; 2006 Aug; 291(2):R315-26. PubMed ID: 16601258
[TBL] [Abstract][Full Text] [Related]
2. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
3. Morphine analgesic tolerance in 129P3/J and 129S6/SvEv mice.
Bryant CD; Roberts KW; Byun JS; Fanselow MS; Evans CJ
Pharmacol Biochem Behav; 2006 Dec; 85(4):769-79. PubMed ID: 17196637
[TBL] [Abstract][Full Text] [Related]
4. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
Juni A; Klein G; Kest B
Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
[TBL] [Abstract][Full Text] [Related]
5. Effects of NMDA receptor channel blockers, dizocilpine and memantine, on the development of opiate analgesic tolerance induced by repeated morphine exposures or social defeats in mice.
Belozertseva IV; Bespalov AYu
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):270-4. PubMed ID: 9750014
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801.
Trujillo KA; Akil H
Science; 1991 Jan; 251(4989):85-7. PubMed ID: 1824728
[TBL] [Abstract][Full Text] [Related]
7. Modulation of morphine analgesia by site-specific N-methyl-D-aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and time.
Nemmani KVS; Grisel JE; Stowe JR; Smith-Carliss R; Mogil JS
Pain; 2004 Jun; 109(3):274-283. PubMed ID: 15157688
[TBL] [Abstract][Full Text] [Related]
8. Acute exposure to saccharin reduces morphine analgesia in the the rat: evidence for involvement of N-methyl-D-aspartate and peripheral opioid receptors.
McNally GP; Westbrook RF
Psychopharmacology (Berl); 2000 Mar; 149(1):56-62. PubMed ID: 10789883
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in hyperalgesia during morphine infusion: effect of gonadectomy and estrogen treatment.
Juni A; Klein G; Kowalczyk B; Ragnauth A; Kest B
Neuropharmacology; 2008 Jun; 54(8):1264-70. PubMed ID: 18457849
[TBL] [Abstract][Full Text] [Related]
10. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids.
Elliott K; Minami N; Kolesnikov YA; Pasternak GW; Inturrisi CE
Pain; 1994 Jan; 56(1):69-75. PubMed ID: 7512709
[TBL] [Abstract][Full Text] [Related]
11. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
Fischer BD; Carrigan KA; Dykstra LA
J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
[TBL] [Abstract][Full Text] [Related]
12. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C.
Mao J; Price DD; Mayer DJ
J Neurosci; 1994 Apr; 14(4):2301-12. PubMed ID: 7908958
[TBL] [Abstract][Full Text] [Related]
13. Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat.
Dunbar SA; Pulai IJ
J Pharmacol Exp Ther; 1998 Feb; 284(2):678-86. PubMed ID: 9454814
[TBL] [Abstract][Full Text] [Related]
14. The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat.
Ben-Eliyahu S; Marek P; Vaccarino AL; Mogil JS; Sternberg WF; Liebeskind JC
Brain Res; 1992 Mar; 575(2):304-8. PubMed ID: 1533339
[TBL] [Abstract][Full Text] [Related]
15. The influence of AMN082, metabotropic glutamate receptor 7 (mGlu7) allosteric agonist on the acute and chronic antinociceptive effects of morphine in the tail-immersion test in mice: Comparison with mGlu5 and mGlu2/3 ligands.
Gawel K; Jenda-Wojtanowska M; Gibula-Bruzda E; Kedzierska E; Filarowska J; Marszalek-Grabska M; Wojtanowski KK; Komsta L; Talarek S; Kotlinska JH
Physiol Behav; 2018 Mar; 185():112-120. PubMed ID: 29294304
[TBL] [Abstract][Full Text] [Related]
16. Effects of N-methyl-D-aspartate receptor antagonists on the analgesia and tolerance to D-Ala2, Glu4 deltorphin II, a delta 2-opioid receptor agonist in mice.
Bhargava HN; Zhao GM
Brain Res; 1996 May; 719(1-2):56-61. PubMed ID: 8782863
[TBL] [Abstract][Full Text] [Related]
17. NMDA antagonist modulation of morphine antinociception in female vs. male rats.
Craft RM; Lee DA
Pharmacol Biochem Behav; 2005 Apr; 80(4):639-49. PubMed ID: 15820534
[TBL] [Abstract][Full Text] [Related]
18. Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist.
Kolesnikov Y; Pasternak GW
J Pharmacol Exp Ther; 1999 Jul; 290(1):247-52. PubMed ID: 10381783
[TBL] [Abstract][Full Text] [Related]
19. Effects of systemic, intracerebral, or intrathecal administration of an N-methyl-D-aspartate receptor antagonist on associative morphine analgesic tolerance and hyperalgesia in rats.
McNally GP; Westbrook RF
Behav Neurosci; 1998 Aug; 112(4):966-78. PubMed ID: 9733203
[TBL] [Abstract][Full Text] [Related]
20. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
